Polyplex Corporation Limited

rs,

, Mumbai- 400 051 The General Manager - Listing Department, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001 SYMBOL: POLYPLEx BSE Scrip Code 524051 Dear Sir(s) Sub: Regul

3%

d Downstream Capabilities …With a Diverse Product Profile… Product Breakdown (Q1FY23 Revenues) 3% 3% 4% 8% 14% 16% 52% 34 Years of Operation At the Forefront of Sustainability and Circula

4%

stream Capabilities …With a Diverse Product Profile… Product Breakdown (Q1FY23 Revenues) 3% 3% 4% 8% 14% 16% 52% 34 Years of Operation At the Forefront of Sustainability and Circular Econ

8%

am Capabilities …With a Diverse Product Profile… Product Breakdown (Q1FY23 Revenues) 3% 3% 4% 8% 14% 16% 52% 34 Years of Operation At the Forefront of Sustainability and Circular Economy

14%

Capabilities …With a Diverse Product Profile… Product Breakdown (Q1FY23 Revenues) 3% 3% 4% 8% 14% 16% 52% 34 Years of Operation At the Forefront of Sustainability and Circular Economy ~2,

16%

ilities …With a Diverse Product Profile… Product Breakdown (Q1FY23 Revenues) 3% 3% 4% 8% 14% 16% 52% 34 Years of Operation At the Forefront of Sustainability and Circular Economy ~2,650 C

52%

es …With a Diverse Product Profile… Product Breakdown (Q1FY23 Revenues) 3% 3% 4% 8% 14% 16% 52% 34 Years of Operation At the Forefront of Sustainability and Circular Economy ~2,650 Custom

100%

ng” process for manufacturing Sarafil rPET film with Post- Consumer Recycled (PCR) content up to 100%. Capacity addition in Thailand & Turkey Ramp up of recent investment for a new post-consumer

20%

s… (Q1 FY 22-23) (FY 21-22) India Rating & Research IND AA- (Positive Outlook) $263mm Revenue# 20% Normalized EBITDA* Margin $52mm Normalized EBITDA* 29% ROCE1 $887mm Revenue# 21% Normalized

29%

AA- (Positive Outlook) $263mm Revenue# 20% Normalized EBITDA* Margin $52mm Normalized EBITDA* 29% ROCE1 $887mm Revenue# 21% Normalized EBITDA* Margin $186mm Normalized EBITDA* 27% ROCE1 …Dri

21%

mm Revenue# 20% Normalized EBITDA* Margin $52mm Normalized EBITDA* 29% ROCE1 $887mm Revenue# 21% Normalized EBITDA* Margin $186mm Normalized EBITDA* 27% ROCE1 …Driven by Strong, Sustainable P

27%

d EBITDA* 29% ROCE1 $887mm Revenue# 21% Normalized EBITDA* Margin $186mm Normalized EBITDA* 27% ROCE1 …Driven by Strong, Sustainable Profitability Widening of the Product Portfolio Operationa

“These are based on certain assumptions as on date and are subject to significant risks and uncertainties, as they could be substantially influenced by several factors which are beyond Company’s control including, but not limited to, fluctuations in foreign exchange rates, changes in key raw material prices, changes in market dynamics, impact of consolidation of subsidiaries and any unexpected production down times due to machinery breakdown, unforeseen delays in project start up etc.”

Factors impacting QoQ

1

Factors impacting YoY

1

Note

1

Factors impacting YoY

▪ Higher volumes on account of startup of BOPP line in Indonesia ▪ Higher Revenue due to rise in sales price of BOPET film on account of ▪ Higher sales prices of BOPET film on account of higher RM cost higher RM cost partially offset by fall in BOPP film prices partially offset by fall in BOPP film prices ▪ Unfavorable impact of FX fluctuation on change in stock on account of consolidation. In Q1 22-23, there is a loss of INR 12.44 crores ($1.61 million) as against a gain of INR 13.68 crores ($1.82 million) in Q4 21-22 ▪ Higher VA resulting in better per unit EBITDA margin ▪ In Q1 22-23, there is an unrealized FX gain of INR 30.20 crores ($ 3.91 million) as against unrealized FX loss of INR 46.58 crores ($ 6.32 million) in Q1 21-22 on account of restatement of foreign currency long term loans 9 EBITDA Evolution Normalized EBITDA Bridge (Q1 22-23 vs Q4 21-22) n o i l l i m D S U 2.3 3.4 3.0 53.0 53.0 52.0 52.0 0.1 54.8 4.0 50.8 1.7 50.8 52.5 Normalised EBITDA - Q4 21-22 Volume VA varian

Note

Polyplex CUF is calculated based on the extant capacity; Industry CUF as per CY, Polyplex CUF as per FY; Industry CUF is based on internal estimates; Expected Global CUF of the Industry will decline in CY22 as per demand supply estimates 30 5 Sustained and Profitable Growth (1/3) Strong Growth Improving Profit Margins Steady Cash Flow Generation Robust Balance Sheet Sales Volume Across All Films (KMT) EBITDA ($mm) and EBITDA Margin (%) & $/kg 8% 12% 6% 7% 18% 0.45 21% 0.49 26% 0.56 21% 0.57 20% 0.61 253 274 306 323 FY19 FY20 FY21 FY22 Sales Volume (KMT) Growth % 87 Q1FY23 Annualised 115 133 171 186 FY19 FY20 FY21 FY22 EBITDA ($mm) Margin % 52 Q1FY23 Annualised EBITDA ($/kg) Cash Flow from Operations1 ($mm) Capex ($mm) & Net Debt ($mm) 105 84 123 109 160 170 149 76 47 18 (57) 53 (66) 67 (75) 71 (38) 54 (53) 4 FY19 FY20 FY21 FY22 Q1FY23 FY19 FY20 FY21 FY22 Q1FY23 Cash Flow after change in NWC ($mm) Change in NWC ($mm) Capex ($mm) Net Debt ($mm) Note: 1 Cash flow from operations have been